Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study

Laetitia Albano; Bernard Banas; Frank Lehner; Maciej Glyda; Ondrej Viklicky; Stefan Schleibner; Malcolm Brown; Nassim Kamar

doi:10.12659/AOT.920041

29 May 2020 : Original article

Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study

Laetitia Albano^{BDE 1}, Bernard Banas^{BDE 2}, Frank Lehner^{BDE 3}, Maciej Glyda^{BDE 4,5}, Ondrej Viklicky^{BDE 6}, Stefan Schleibner^{CDE 7}, Malcolm Brown^{ADE 8}, Nassim Kamar^{BDE 9*}

DOI: 10.12659/AOT.920041

Ann Transplant 2020; 25:e920041

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Supplementary Table 4 Comparison of definitions of ECDs in clinical trials.

	Extended-criteria donor characteristics
United Network for Organ Sharing (UNOS) []¹⁴
ELITE-Symphony []¹⁷
OSAKA []⁹
The definition of ECD was calculated retrospectively in the OSAKA study. ECD – extended-criteria donors; OSAKA – ptimising immunouppression fter idney transplantation with dvagraf™; UNOS – United Network for Organ Sharing.

Back to the Article

Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors – A Post Hoc Analysis of the Prospective OSAKA Study

Your Privacy